WhichRecall
Class IIReported 2026-03-11

Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106-02; c) 10g, NDC 84385-106-06; d) 25g, NDC 84385-106-03; d) 50g, NDC 84385-106-04 Manufacturer: Harbin Jixianglong Biotech Co., Ltd., North of Baoan Road, East of Changqing Street, Limin Development Zone, Harbin, China

Recalled by Harbin Jixianglong Biotech Co., Ltd.

Reason for Recall

CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution

Advertisement
Recall Number
D-0379-2026
Classification
Class II
Status
Ongoing
Category
drug
Initiated
2026-02-13
Reported
2026-03-11
Distribution
Nationwide within the United States
Code Info
Lot #: CP-030-20250711, Exp. Date Jul. 24th, 2027
Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.
Advertisement